Literature DB >> 10720026

Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men.

J Q Purnell1, S E Kahn, J J Albers, D N Nevin, J D Brunzell, R S Schwartz.   

Abstract

How weight loss improves lipid levels is poorly understood. Cross-sectional studies have suggested that accumulation of fat in intra-abdominal stores (IAF) may lead to abnormal lipid levels, increased hepatic lipase (HL) activity, and smaller low density lipoprotein (LDL) particle size. To determine what effect loss of IAF would have on lipid parameters, 21 healthy older men underwent diet-induced weight loss. During a period of weight stability before and after weight loss, subjects underwent studies of body composition, lipids, measurement of postheparin lipoprotein and HL lipase activities, cholesteryl ester transfer protein activity, and insulin sensitivity (Si). After an average weight loss of 10%, reductions in fat mass, IAF, and abdominal s.c. fat were seen, accompanied by reductions in levels of triglyceride, very low density lipoprotein cholesterol, apolipoprotein B, and HL activity. High density lipoprotein-2 cholesterol and Si increased. In those subjects with pattern B LDL at baseline, LDL particle size increased. Cholesteryl ester transfer protein activity did not change. Changes in IAF and Si correlated with a decrease in HL activity (although not independently of each other). In summary, in men undergoing diet-induced weight loss, only loss of IAF was found to be associated with a reduction in HL, which is associated with beneficial effects on lipid levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720026     DOI: 10.1210/jcem.85.3.6402

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

Review 1.  Diet and low-density lipoprotein particle size.

Authors:  Sophie Desroches; Benoît Lamarche
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113

Review 2.  Subcutaneous fat loss is greater than visceral fat loss with diet and exercise, weight-loss promoting drugs and bariatric surgery: a critical review and meta-analysis.

Authors:  C Merlotti; V Ceriani; A Morabito; A E Pontiroli
Journal:  Int J Obes (Lond)       Date:  2017-02-02       Impact factor: 5.095

Review 3.  The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype.

Authors:  John D Brunzell; Alberto Zambon; Samir S Deeb
Journal:  Biochim Biophys Acta       Date:  2011-09-25

4.  Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

Authors:  M Cnop; P J Havel; K M Utzschneider; D B Carr; M K Sinha; E J Boyko; B M Retzlaff; R H Knopp; J D Brunzell; S E Kahn
Journal:  Diabetologia       Date:  2003-04-10       Impact factor: 10.122

5.  Cholesteryl ester transfer protein protects against insulin resistance in obese female mice.

Authors:  David A Cappel; Brian T Palmisano; Christopher H Emfinger; Melissa N Martinez; Owen P McGuinness; John M Stafford
Journal:  Mol Metab       Date:  2013-09-02       Impact factor: 7.422

Review 6.  The role of triglycerides in cardiovascular risk.

Authors:  Puneet Gandotra; Michael Miller
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

7.  Mice lacking hepatic lipase are lean and protected against diet-induced obesity and hepatic steatosis.

Authors:  Harvey K Chiu; Kun Qian; Kayoko Ogimoto; Gregory J Morton; Brent E Wisse; Nalini Agrawal; Thomas O McDonald; Michael W Schwartz; Helén L Dichek
Journal:  Endocrinology       Date:  2010-01-07       Impact factor: 4.736

8.  Effects of weight loss on lipid transfer proteins in morbidly obese women.

Authors:  Markus W Laimer; Julia Engl; Alexander Tschoner; Susanne Kaser; Andreas Ritsch; Tobias Tatarczyk; Markus Rauchenzauner; Helmut Weiss; Franz Aigner; Josef R Patsch; Christoph F Ebenbichler
Journal:  Lipids       Date:  2009-09-30       Impact factor: 1.880

9.  Reversal of small, dense LDL subclass phenotype by normalization of adiposity.

Authors:  Patty W Siri-Tarino; Paul T Williams; Harriet S Fernstrom; Robin S Rawlings; Ronald M Krauss
Journal:  Obesity (Silver Spring)       Date:  2009-06-04       Impact factor: 5.002

Review 10.  Dyslipidemias in the prevention of cardiovascular disease: risks and causality.

Authors:  Ian Graham; Marie-Therese Cooney; David Bradley; Alexandra Dudina; Zeljko Reiner
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.